Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
31/05/202214:59PR Newswire (US)FDA Accepts Dupixent® (dupilumab) for Priority Review in Adults with Prurigo NodularisNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/05/202220:11TipRanksRegeneron & Sanofi Get FDA’s Green Light for DupixentNASDAQ:REGNRegeneron Pharmaceuticals Inc
21/05/202221:00PR Newswire (US)Evkeeza® (evinacumab) Phase 3 Trial Demonstrates 48% LDL-C Reduction in Children with Ultra-rare Form of High CholesterolNASDAQ:REGNRegeneron Pharmaceuticals Inc
21/05/202205:42Dow Jones NewsFDA Grants Regeneron Approval for Dupixent in Inflammatory Disorder TreatmentNASDAQ:REGNRegeneron Pharmaceuticals Inc
21/05/202205:15PR Newswire (US)FDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic EsophagitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
20/05/202211:10TipRanksCredit Suisse Sticks to Their Buy Rating for Regeneron (REGN)NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/05/202206:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
17/05/202221:00PR Newswire (US)Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics EntrepreneurNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/05/202203:13PR Newswire (US)High School Scientists from Around the World Win Nearly $8M in Awards, Scholarships at Regeneron International Science and Engineering FairNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/05/202201:52PR Newswire (US)High School Scientists from Around the World Win Nearly $8M in Awards, Scholarships at Regeneron International Science and Engineering FairNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202213:48TipRanksRegeneron (REGN) Receives a Hold from Robert W. BairdNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202202:39TipRanksRegeneron (REGN) Gets a Hold Rating from Morgan StanleyNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202222:23TipRanksJ.P. Morgan Sticks to Its Hold Rating for Regeneron (REGN)NASDAQ:REGNRegeneron Pharmaceuticals Inc
04/05/202220:30PR Newswire (US)Regeneron Reports First Quarter 2022 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/05/202207:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/05/202206:15PR Newswire (US)Regeneron Announces Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
22/04/202206:22Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
22/04/202206:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/04/202223:46Dow Jones NewsCheckmate Pharmaceuticals Shares Take Flight on Regeneron DealNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/04/202221:47Dow Jones NewsRegeneron to Buy Checkmate Pharmaceuticals for About $250 MillionNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/04/202221:00GlobeNewswire Inc.Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor TypesNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/04/202221:00PR Newswire (US)Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor TypesNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/04/202221:53Dow Jones NewsFDA Extends Review of Regeneron's REGEN-COV Covid-19 DrugNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/04/202221:00PR Newswire (US)U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202208:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202206:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/04/202206:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/04/202206:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/04/202214:59PR Newswire (US)Dupixent® (dupilumab) Approved by European Commission for Children Aged 6 to 11 Years with Severe Asthma with Type 2 InflammationNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/04/202206:05PR Newswire (US)Regeneron to Report First Quarter 2022 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2022NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN